How to buy Living Cell Technologies shares | A$0.015
Own Living Cell Technologies shares in just a few minutes.
We’re committed to our readers and editorial independence. We don’t compare all products in the market and may receive compensation when we refer you to our partners, but this does not influence our opinions or reviews. Learn more about Finder.
Living Cell Technologies Limited is a biotechnology business based in Australia. Living Cell Technologies shares (LCT) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Its last market close was $0.015 – the same closing value as a week prior. Living Cell Technologies has a trailing 12-month revenue of around $553,692.
How to buy shares in Living Cell Technologies
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Living Cell Technologies . Find the share by name or ticker symbol: LCT. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Living Cell Technologies reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price of $0.015, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check in on your investment. Congratulations, you own a part of Living Cell Technologies . Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
🧪How we chose these brokersFor our Top Picks, we compared our Finder partners using a proprietary algorithm in August 2020. Keep in mind that our top picks may not always be the best for you, and you're encouraged to compare for yourself to find one that works for you. Read our full methodology here to find out more.
What's in this guide?
- Living Cell Technologies key stats
- Compare share trading platforms
- Is Living Cell Technologies stock a buy or sell?
- Living Cell Technologies performance over time
- Living Cell Technologies 's financials
- How volatile are Living Cell Technologies shares?
- Does Living Cell Technologies pay a dividend?
- Other common questions
How has coronavirus impacted Living Cell Technologies 's share price?
Since the stock market crash in March caused by coronavirus, Living Cell Technologies 's share price has had significant negative movement.
Its last market close was $0.015, which is 21.05% down on its pre-crash value of $0.019 and 66.67% up on the lowest point reached during the March crash when the shares fell as low as $0.009.
If you had bought $1,000 worth of Living Cell Technologies shares at the start of February 2020, those shares would have been worth $526.32 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $789.47.
Living Cell Technologies share priceUse our graph to track the performance of LCT stocks over time.
Living Cell Technologies shares at a glance
|Latest market close||AUDA$0.015|
|52-week range||AUDA$0.009 - AUDA$0.022|
|50-day moving average||AUDA$0.0158|
|200-day moving average||AUDA$0.0143|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||AUDA$-0.006|
Standard brokerage - Australian shares
Share Trading Account Offer
Competitive broker fees on Australian and international shares
- Brokerage - AU shares: From AUD 5 or 0.05%
- Brokerage - US shares: USD 0
- Sign-up process: Instant
- Support - After hours: Yes
Important: Share trading carries risk of capital loss.
Compare share trading platforms
Is it a good time to buy Living Cell Technologies stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Living Cell Technologies price performance over time
|1 week (2020-10-22)||0%|
|1 month (2020-09-29)||-6.25%|
|3 months (2020-07-29)||15.38%|
|6 months (2020-04-29)||7.14%|
|1 year (2019-10-29)||-31.82%|
|2 years (2018-10-29)||-70.00%|
|3 years (2017-10-27)||-93.62%|
|5 years (2015-10-29)||-71.70%|
Living Cell Technologies financials
|Gross profit TTM||$553,692|
|Return on assets TTM||-32.18%|
|Return on equity TTM||-27.6%|
|Market capitalisation||$9.1 million|
TTM: trailing 12 months
Living Cell Technologies share dividends
We're not expecting Living Cell Technologies to pay a dividend over the next 12 months.
Living Cell Technologies share price volatility
Over the last 12 months, Living Cell Technologies 's shares have ranged in value from as little as $0.009 up to $0.022. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Living Cell Technologies 's is 0.9729. This would suggest that Living Cell Technologies 's shares are less volatile than average (for this exchange).
Living Cell Technologies overview
Living Cell Technologies Limited, a biotechnology company, discovers, develops, and commercializes regenerative treatments that use naturally occurring cells to restore functions in New Zealand. The company's lead product is NTCELL, an alginate coated capsule, which is in clinical trials for the treatment of Parkinson's disease. It also develops LP-003, a peptide drug that reduces caloric intake targeting obesity; and LC-002, a novel calcitonin gene-related peptide antagonist targeting migraine. Living Cell Technologies Limited has a research collaboration agreement with the University of Auckland to identify products that utilize patented novel peptide synthetic chemistry technology for the treatments for obesity and migraine. The company was founded in 1987 and is based in Melbourne, Australia.
Frequently asked questions
More guides on Finder
Where to buy Xbox One racing wheels online in Australia
A list of stores to buy Xbox One racing wheels online in Australia.
Where to buy Xbox One consoles online in Australia
A list of stores to buy Xbox One consoles online in Australia.
Where to buy Xbox One chargers online in Australia
A list of stores to buy Xbox One chargers online in Australia.
Where to buy Xbox One cables online in Australia
A list of stores to buy Xbox One cables online in Australia.
Where to buy Xbox 360 online in Australia
A list of stores to buy Xbox 360 online in Australia.
Where to buy Xbox 360 remotes online in Australia
A list of stores to buy Xbox 360 remotes online in Australia.
Where to buy Xbox 360 racing wheels online in Australia
A list of stores to buy Xbox 360 racing wheels online in Australia.
Where to buy Xbox 360 headsets online in Australia
A list of stores to buy Xbox 360 headsets online in Australia.
Where to buy Xbox 360 games online in Australia
A list of stores to buy Xbox 360 games online in Australia.
Where to buy Xbox 360 gamepads & standard controllers online in Australia
A list of stores to buy Xbox 360 gamepads & standard controllers online in Australia.
Ask an Expert